Literature DB >> 9099592

Panhypopituitarism due to Rathke's cleft cyst associated with pituitary oncocytoma.

N Yamakita1, T Ikeda, T Murai, M Kimura, T Komaki, K Miura, M Iwamura, T Hirata.   

Abstract

A 38-year-old male with panhypopituitarism due to Rathke's cleft cyst associated with a pituitary oncocytoma is reported. The presenting signs were general myalgia and slight fatigue. Endocrine examinations revealed panhypopituitarism. Magnetic resonance imaging disclosed a suprasellar cystic lesion of the pituitary gland. Cytological examination demonstrated ciliated cells in the mucinous fluid flowing from the cyst during the pituitary operation. A pituitary oncocytoma with randomly scattered S-100 immunoreactive cells was found upon histologic examination of the nodular tissue curettaged from the internal wall of the cyst. These results suggest that the pituitary adenoma was derived from folliculostellate cells included in the Rathke's cleft wall.

Entities:  

Mesh:

Year:  1997        PMID: 9099592     DOI: 10.2169/internalmedicine.36.107

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  3 in total

1.  Intra-sellar salivary gland-like pleomorphic adenoma arising within the wall of a Rathke's cleft cyst.

Authors:  L Chimelli; M R Gadelha; K Une; S Carlos; P J Pereira; J L Santos; P N Filho; F Duarte
Journal:  Pituitary       Date:  2000-12       Impact factor: 4.107

Review 2.  Collision lesions of the sella: co-existence of craniopharyngioma with gonadotroph adenoma and of Rathke's cleft cyst with corticotroph adenoma.

Authors:  N Karavitaki; B W Scheithauer; J Watt; O Ansorge; M Moschopoulos; A V Llaguno; J A H Wass
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

3.  Synchronous and bilateral oncocytic carcinoma of the breast: A case report and review of the literature.

Authors:  Hiroko Itagaki; Tomoko Yamamoto; Atsuko Hiroi; Kunio Kawanishi; Eiichiro Noguchi; Tetsuya Ohchi; Takako Kamio; Shingo Kameoka; Hideaki Oda; Yoji Nagashima
Journal:  Oncol Lett       Date:  2017-01-18       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.